URAC Specialty Pharmacy Services vs. URAC Specialty Pharmacy Accreditation — What's the Difference?

Start Here: The Threshold Question

Before reviewing any other comparison, answer one question:

Does your organization directly dispense specialty medications to patients?

• Yes → Your organization is a licensed specialty pharmacy. The applicable program is URAC Specialty Pharmacy Accreditation. See URAC Specialty Pharmacy Accreditation Consulting.
• No → Your organization provides support services to licensed specialty pharmacy partners. The applicable program is URAC Specialty Pharmacy Services Accreditation. Continue reading.

If your organization has both a dispensing function and a support services function under the same legal entity, IHS conducts structural analysis to determine the appropriate program or whether both programs apply to different operational divisions.

Side-by-Side Comparison

Who Each Program Serves

URAC Specialty Pharmacy Accreditation — Organization Types

This program is designed for any licensed pharmacy that dispenses specialty medications and provides patient management services to patients with complex, chronic conditions. Organization types include:

• Independent specialty pharmacies serving complex disease states (oncology, rare disease, immunology, neurology)
• Health-system specialty pharmacies, including 340B-enrolled operations
• PBM-owned or PBM-affiliated specialty pharmacy subsidiaries
• National specialty pharmacy chains with multiple dispensing locations
• Infusion pharmacy operations with specialty medication dispensing components
• Specialty pharmacies seeking manufacturer limited distribution drug (LDD) network inclusion

URAC Specialty Pharmacy Services Accreditation — Organization Types

This program is designed for organizations providing the support layer of the specialty pharmacy ecosystem. Organization types include:

• Hub services organizations (HSOs) — patient access, benefits investigations, prior authorization support, copay assistance, patient assistance program administration
• Manufacturer patient support programs — pharmaceutical manufacturer-sponsored patient services for specific specialty therapeutic areas
• Specialty pharmacy support centers — organizations providing patient communication, adherence support, and quality management services as a support layer to licensed dispensing pharmacies
• Specialty distribution support organizations — entities coordinating limited distribution drug logistics, patient communication, and support services
• Integrated health system support functions — health system departments providing clinical support services for affiliated specialty pharmacy dispensing operations
• Third-party patient services vendors — organizations contracted to provide patient services components to a specialty pharmacy network

Standards Depth — What Each Program Evaluates

Specialty Pharmacy Accreditation — Standards Modules

The full Specialty Pharmacy program (current version: v6.0, released October 2025) encompasses nine operational modules with more than 40 standards:

1. Risk Management (RM) — ongoing operational risk assessment and mitigation
2. Operations and Infrastructure (OPIN) — governance, personnel, facilities, training
3. Performance Monitoring and Improvement (PMI) — quality metrics, monitoring cycles, improvement processes
4. Consumer Protection and Empowerment (CPE) — patient rights, grievances, appeals
5. Pharmacy Operations (P-OPS) — licensure, regulatory compliance, operational controls
6. Medication Distribution (P-MD) — dispensing accuracy, labeling, packaging, delivery
7. Patient Service and Communication (P-PSC) — patient outreach, education, communication protocols
8. Patient Management (PM) — clinical coordination, drug utilization review, therapeutic monitoring
9. Reporting Performance Measures (RPT) — mandatory quality measure data submission to URAC

Specialty Pharmacy Services Accreditation — Standards Domains

The Services program focuses on the support-organization-relevant domains — omitting the dispensing, medication distribution, and measures reporting modules that do not apply to non-dispensing entities:

• Patient Service and Communication — patient outreach, education delivery, communication documentation
• Quality Management and Improvement — formal quality management system with defined metrics and improvement cycles
• Risk Management — ongoing risk analysis, mitigation strategies, regulatory monitoring
• Consumer Protection and Empowerment — grievance and appeals processes, patient rights disclosures
• Operations and Infrastructure — organizational governance, personnel qualifications, training
• Regulatory Compliance Monitoring — documented processes for tracking and responding to regulatory changes

The absence of pharmacy operations, medication distribution, patient management, and measures reporting modules is not a limitation of the Services credential — it reflects the structural difference between the two programs. The Services credential evaluates everything within the scope of what a support organization does.

Market Context — Why Both Programs Exist

The specialty pharmacy market has evolved from a model where a single licensed pharmacy managed both dispensing and patient services, to a complex ecosystem where dispensing pharmacies, hub services organizations, pharmaceutical manufacturers, and third-party patient services vendors each play distinct roles in the specialty medication journey.

As this ecosystem has matured, URAC recognized that quality standards applied only to the dispensing pharmacy missed a substantial portion of the patient experience. A patient receiving a specialty medication for a rare disease interacts with a hub services organization for prior authorization, a manufacturer patient support program for copay assistance, and potentially a separate clinical coordination service — all before ever receiving their medication from the dispensing pharmacy.

URAC Specialty Pharmacy Services Accreditation extends quality validation into that support layer. For pharmaceutical manufacturers and specialty pharmacy networks evaluating hub services partners, it provides an independently validated quality signal in a market where quality differentiation among support organizations is otherwise difficult to assess objectively.

Accreditation Market Positioning

• URAC Specialty Pharmacy Accreditation is recognized by approximately two-thirds of payers as the preferred specialty pharmacy quality credential for dispensing pharmacies
• Major PBM specialty networks — including Express Scripts, CVS Caremark, and OptumRx — accept URAC accreditation for network participation (with OptumRx additionally requiring NABP accreditation for its network)
• URAC Specialty Pharmacy Services Accreditation is currently voluntary with no universal contractual mandate, but is gaining recognition as the specialty pharmacy support services market matures and quality accountability extends beyond the dispensing pharmacist

How IHS Helps You Select the Right Program

Misidentifying the applicable URAC program is among the most costly early errors in the accreditation process. An organization that begins documentation under the wrong standards set — and advances through multiple phases before the error is caught — must restart documentation work under the correct program, losing all elapsed time and documentation investment.

IHS begins every pharmacy accreditation engagement with program navigator analysis: a structured evaluation of your organization's functions, licensure status, service model, and operational scope against URAC's program eligibility criteria. This analysis produces a written determination of the correct program before any documentation work begins.

For organizations with complex structures — integrated health systems with both dispensing and support operations, pharmaceutical manufacturers with both patient support programs and affiliated pharmacies, or specialty pharmacy networks with in-house hub services functions — program navigator analysis identifies how different organizational components map to different URAC credentials and how to sequence accreditation strategy efficiently.

IHS is led by Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC — with direct institutional knowledge of how URAC's pharmacy program portfolio is structured. That background is directly relevant to program selection decisions that determine which standards apply to your organization.

Program Selection Decision Guide

Choose URAC Specialty Pharmacy Accreditation if:

• Your organization holds a pharmacy dispensing license and directly dispenses specialty medications to patients
• You provide clinical patient management services alongside dispensing
• Your PBM contracts require URAC accreditation for specialty network participation
• You are seeking access to manufacturer limited distribution drug networks that require dispensing pharmacy accreditation
• You are a health-system specialty pharmacy or 340B-enrolled dispensing operation

Choose URAC Specialty Pharmacy Services Accreditation if:

• Your organization provides support services to licensed specialty pharmacy partners without directly dispensing medications
• You operate as a hub services organization, manufacturer patient support program, or specialty pharmacy support center
• You want to demonstrate independently validated quality standards to pharmaceutical manufacturer or specialty pharmacy network partners
• You are building quality management infrastructure to support hub services contract growth
• You provide patient access, benefits investigation, prior authorization support, or clinical coordination services

Contact IHS for Program Navigator Analysis if:

• Your organization has both dispensing and support service functions
• You are uncertain whether your support services qualify as "specialty pharmacy services" under URAC's eligibility criteria
• You are a pharmaceutical manufacturer considering whether your patient support program qualifies for this credential
• You want to understand how URAC Specialty Pharmacy Services Accreditation compares to ACHC accreditation for specialty pharmacy support organizations

Not Sure Which Program Applies? IHS Resolves It.

Program selection is the first decision in any URAC pharmacy accreditation engagement — and the most consequential. IHS conducts program navigator analysis as the opening step of every engagement, providing a written determination before any documentation investment is made.

Led by Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC — IHS brings direct institutional knowledge of URAC's program portfolio to every program selection discussion.